Podcast Episode Details

Back to Podcast Episodes
ETF Showdown

ETF Showdown



Don and Tom tackle the “big three” global equity ETFs—Vanguard VT, Dimensional DFAW, and Avantis AVGE—breaking down their diversification, costs, risk/return assumptions, style tilts (small/value vs large/growth), and geographic/sector weights. They highlight how DFA and Avantis add microcaps and factor tilts that Vanguard’s index omits, why fees are “pennies” but differences in construction matter, and why “rules-based” is more accurate than “active.” Listener questions cover lottery winnings (lump sum vs annuity), the collapse of Publishers Clearinghouse payouts, and Ameriprise’s pricey SMA accounts. The theme: investing lives in the middle ground—balancing risk, cost, and logic.

0:04 Middle-dweller banter and show open

0:54 Why ETFs replaced mutual funds as the easy route

1:23 The “big three” global ETFs: VT, AVGE, DFAW

2:34 Which is “better”? Spoiler: none—or all

2:56 Diversification: DFAW 13,700 stocks vs VT’s 10,000

4:00 Expense ratios: Vanguard’s cost advantage

4:32 Risk/return projections and why they’re guesses

6:22 Microcaps explain much of the differences

7:55 Why small/value stocks historically outperform

8:55 Style box breakdown: small vs large allocations

9:45 U.S. vs international exposure: “pandering portfolios”

10:57 Tech vs financials: sector allocations diverge

12:09 Recent performance snapshots, short vs long term

13:34 Index (VT), Factor (DFAW), Rules-based tilt (AVGE)

15:25 Long-term results: Avantis beats Vanguard despite higher fee

16:15 Risk/return symmetry: you could make a lot, lose a lot

16:45 Listener Q&A: $2B Powerball jackpot—lump sum or annuity?

18:01 Publishers Clearinghouse collapse leaves winners unpaid

21:07 Listener Q&A: Ameriprise SMA fees and pitfalls

23:48 Why Ameriprise’s “nice” advisors are still costly

Learn more about your ad choices. Visit megaphone.fm/adchoices


Published on 2 months, 4 weeks ago






If you like Podbriefly.com, please consider donating to support the ongoing development.

Donate